APP and Alzheimer disease: This research aimed to assess the effect of VAD on the cognitive function and pathological mechanism of AD and determine the intestinal microbiota changes driven by VAD in the amyloid precursor protein/presenilin 1 (APP/PS1) transgenic mice.